Tweets
Should you worry about giving TNFi to RA pts after a cancer diagnosis?
Medicare data with colorectal, lung, prostate Ca:
TNFi pts survival no worse (numerically better) than csDMARDs
Cancer pts deserve good RA treatment!
#ACR24 ABST0202 Suarez-Almazor @MDAndersonNews @RheumNow… https://t.co/aR75hJQ6YK https://t.co/ptDYCsOpXN
Dr. John Cush @RheumNow ( View Tweet )
2 months 1 week ago
ANA neg, but ENA pos
should we care about that result?
PPV 5.5% here
(similar to 6% prev @EricFMorand: https://t.co/7Lo0DgHtXT)
and how many really needed the serology? Anxiety?
Surely pos ENA w neg ANA might be more hassle than help. So what to do?⬇️
#ACR24 ABST1930 @RheumNow… https://t.co/lZ1TJxTqhs https://t.co/itx0TCFFjl
Dr. John Cush @RheumNow ( View Tweet )
2 months 2 weeks ago
Great table re:side effects of even low dose steroids in RA
Likely generalizes to other diseases ie PMR, SLE
P in prednisone stands for poison!
#ACR24 @RheumNow https://t.co/2bFy6dwl96 https://t.co/YDtjSX054I
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 months 2 weeks ago
TAPIR study of continuing vs stopping steroids in ANCA vasculitis in remission. Relapse at month 6 in 16% vs 4%. OR 4.22, but low rate in either group. If treated Rituximab, no difference! Merkel et al. @RheumNow #ACR24 Abstr#0774 #ACRbest https://t.co/F9DOBLrjVq https://t.co/BtphAuEopA
Dr. John Cush @RheumNow ( View Tweet )
2 months 2 weeks ago
54K Peptic Ulcers Annually (12.13.2024)
https://t.co/18FiQx1YQA https://t.co/32UZi9XafS
Dr. John Cush @RheumNow ( View Tweet )
2 months 2 weeks ago
Improvements in Pain and Fatigue in Bimekizumab
Dr. Philip Mease discusses abstract 2368, presented at the 2024 ACR Convergence meeting in Washington, DC.
https://t.co/ON09z9yTuJ https://t.co/650TUdHwYm
Dr. John Cush @RheumNow ( View Tweet )
2 months 2 weeks ago
Vaccine Responses:The DMARD Counts
Dr. David Liew reviews abstracts 0247, 0248, 1988, 1009, reporting from Melbourne, Australia for the 2024 ACR Convergence meeting.
https://t.co/0qDGRkT64B https://t.co/dO9EvhD1NE
Dr. John Cush @RheumNow ( View Tweet )
2 months 2 weeks ago
How do you manage skin in Sscl?
-RNA pol III + high risk for skin progression.
-Limited+ low risk + stable Sscl no need for immunesuppresors.
-Look for EF in pts with generalized morphea.
-Ttnt of skin depending on other organ involvements.
-If no Raynaud’s/hands spared think of… https://t.co/DZzhShKzS8 https://t.co/J9Qg1Lk2Wl
Dr. John Cush @RheumNow ( View Tweet )
2 months 2 weeks ago
#ACR24 Year in Review:
💡GLP1i significantly decreased knee OA pain over time (or was it the wt loss itself?🤨)
💡CD19 CAR T-Cell therapy has potential to treat/cure many autoimmune diseases (are risks and $ worth the benefit?)
💡 High risk of CV events within 30 days of gout… https://t.co/g3egOpCYNr https://t.co/KMiOEP7pSg
Dr. John Cush @RheumNow ( View Tweet )
2 months 2 weeks ago
Sarcoidosis is biopsy supported not proven”
-Dx is clinical with broad ddx.
-Assess organ involvement in all pts.
-Whole body PET can help assess disease activity (not in CNS disease)
-MR brain with pituitary cuts helpful in CNS sarcoid.
#ACR24 @ACRheum @RheumNow… https://t.co/Ka1cHtFOqj
Dr. John Cush @RheumNow ( View Tweet )
2 months 2 weeks ago
RheumNow Live 2025: Feb 8-9, Dallas, TX! 🔬 Don’t miss top experts on Psoriatic Disease:
➡️ A. Ogdie: Preventing PsA
➡️ A. Kavanaugh: Biologic Therapies
➡️ K. Gordon: Head-to-Head Studies
Register now!
https://t.co/9qnqtpkwpT https://t.co/95TGS56vyA
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 months 2 weeks ago
Best of 2024: Lung Cancer in Rheumatoid Arthritis and Interstitial Lung Disease
https://t.co/Sd3H5Tzhtf https://t.co/guXzL5bc6R
Dr. John Cush @RheumNow ( View Tweet )
2 months 2 weeks ago